Detection of different forms of variant transthyretin (Met30) in cerebrospinal fluid

Neuroscience Letters

Volumn 238, Issue 3, 1997, Pages 123-126

  Ando, Yukio ^a,b   Suhr, Ole ^a   Yamashita, Taro ^b   Ohlsson, Per Ingval ^a   Holmgren, Gösta ^a   Obayashi, Konen ^b   Terazaki, Hisayasu ^b   Mambule, Charles ^a   Uchino, Makoto ^b   Ando, Masayuki ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Amyloidosis; Cerebrospinal fluid; Familial amyloidotic polyneuropathy; Mass spectrometry; Transthyretin; Variant TTR

Indexed keywords

PREALBUMIN;

ADULT; AMYLOID NEUROPATHY; ARTICLE; CENTRIFUGATION; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FAMILIAL DISEASE; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN VARIANT;

ADULT; AMYLOID NEUROPATHIES; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PREALBUMIN; VARIATION (GENETICS);

EID: 0031555299     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00868-9     Document Type: Article

References (19)

1. Ando Y., Araki S., Ando M. Transthyretin and familial amyloidotic polyneuropathy. Intern. Med. 32:1993;920-922.
2. Ando Y., Tanaka Y., Nakazato M., Yamashita T., Tashima K., Sakashita N., Suga M., Uchino M., Ando M. Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy Type I following liver transplantation. Biochem. Biophys. Res. Commun. 211:1995;354-358.
3. Ando Y., Tanaka Y., Ando E., Yamashita T., Nishida Y., Tashima K., Suga M., Uchino M., Ando M. Effect of liver transplantation on autonomic dysfunction in familial polyneuropathy Type I. Lancet. 345:1995;195-196.
4. Ando Y., Ohlsson P.-I., Suhr O., Nyhlin N., Yamashita T., Holmgren G., Danielsson A., Sandgren O., Uchino M., Ando M. A new simple and rapid screening method for variant transthyretin (TTR) related amyloidosis. Biochem. Biophys. Res. Commun. 228:1996;480-483.
5. Ando Y., Nyhlin N., Suhr O., Holmgren G., Uchida K., Sahly M.E., Yamashita T., Nakamura M., Uchino M., Ando M. Oxidative stress is found in amyloid deposits in systemic amyloidosis. Biochem. Biophys. Res. Commun. 232:1997;497-502.
6. Araki S. Type I familial amyloidotic polyneuropathy (Japanese type). Brain Dev. 6:1984;128-133.
7. Benson M.D., Uemichi T. Transthyretin amyloidosis, Amyloid Int. J. Clin. Invest. 3:1996;44-56.
8. Holmgren G., Bergstrom S., Drugge U., Lundgren E., Nording-Sikstrom C., Sandgren O., Steen L. Homozygosity for the transthyretin-Met30-gene in seven individuals with familial amyloidosis with polyneuropathy detected by restriction enzyme analysis of amplified genomic DNA sequences. Clin. Genet. 41:1992;39-41.
9. Holmgren G., Ericzon B.G., Groth C.G., Steen L., Suhr O., Andersen O., Wallin B.G., Seymour A., Richardson S., Hawking P.M. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet. 341:1993;113-116.
10. Hutchinson W.L., Alves I.L., Saraiva M.J., Pepys M.B. Post-translational modification of serum TTR. Neuromusc. Disord. 6(S1):1996;S16.
11. Kishikawa M., Nakanishi T., Miyazaki T., Shimizu A., Nakazato M., Kangawa K., Matsuo H. Simple detection of abnormal serum transthyretin from patients with familial amyloidotic polyneuropathy by high performance liquid chromatography/electrospray mass-spectrometry using material precipitated with specific antiserum. J. Mass Spec. 31:1996;112-114.
12. Nakanishi T., Shimizu A., Okamoto N., Ingendoh A., Kanai M. Analysis of serum protein precipitated with antiserum by matrix-assisted laser desorption ionization/time-of-flight and electrospray ionization mass spectrometry as a clinical laboratory test. J. Am. Soc. Mass Spec. 6:1995;854-859.
13. Petersen R.B., Goren H., Cohen M., Richardson S.L., Tresser N., Lynn A., Gali M., Estes M., Gambetti P. Transthyretin amyloidosis: a new mutation associated with dementia. Ann. Neurol. 41:1997;307-313.
14. Saeki Y., Ueno S., Yorifuji S., Sugiyama Y., Ide Y., Matsuzawa Y. New mutant gene (transthyretin Arg 58) in case with hereditary polyneuropathy detected by non-isotope method of single-strand conformation polymorphism analysis. Biochem. Biophys. Res. Commun. 180:1991;380-385.
15. Sasaki H., Sakai Y., Matsuo H., Goto I., Kuroiwa Y., Sahashi I., Takahashi A., Shinoda T., Isobe T., Takagi Y. Diagnosis of familial amyloidotic polyneuropathy by recombinant DNA techniques. Biochem. Biophys. Res. Commun. 125:1984;636-642.
16. Skinner M., Lewis W.D., Jones L.A., Kasirsky J., Kane K., Ju S.T., Jenkins R., Falk R.H., Simms R.W., Cohen A.S. Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann. Intern. Med. 120:1994;133-134.
17. Suhr O.B., Holmgren G., Steen L., Wikström L., Norden G., Friman S., Duraj F.F., Groth C.G. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation. 60:1995;933-938.
18. Ueno S., Fujimura H., Yorifuji S., Nakamura Y., Takahashi M., Tarui S., Yanagihara T. Familial amyloidotic polyneuropathy associated with the transthyretin Cys 114 gene in a Japanese kindred. Brain. 15:1992;1275-1289.
19. Weisner B., Roethig H.J. The concentration of prealbumin in cerebrospinal fluid (CSF), indicator of CSF circulation disorders. Eur. Neurol. 22:1983;96-105.